Första AP-fonden’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.45M | Sell |
|
|||||
|
2025
Q1 | $2.18M | Sell |
|
|||||
|
2024
Q4 | $2.76M | Sell |
|
|||||
|
2024
Q3 | $2.56M | Sell |
|
|||||
|
2024
Q2 | $4.49M | Sell |
|
|||||
|
2024
Q1 | $4.72M | Buy |
|
|||||
|
2023
Q4 | $2.32M | Sell |
|
|||||
|
2023
Q3 | $2.05M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1.44M | Buy |
|
|||||
|
2022
Q2 | $253K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $1.43M | Buy |
|
|||||
|
2020
Q2 | $1.49M | Sell |
|
|||||
|
2020
Q1 | $1.19M | Buy |
|